{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-054744","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2026-05-12T12:10:23+00:00","discovered_at":"2026-05-12T12:15:00.293065+00:00","generated_at":"2026-05-12T12:19:13.583374+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeuroOne Q2 product revenue up 72% to $2.4M; net loss narrows to $2.1M","bullets":["Product revenue $2.4M (+72% YoY); no license revenue vs $3.0M in prior year first half.","Net loss $2.1M ($0.25/sh) vs $2.3M ($0.44/sh) in same quarter last year.","Cash $2.8M; working capital $5.7M; no debt outstanding; accounts receivable $2.4M.","16 trigeminal neuralgia cases completed with all patients reportedly pain free.","Christopher Volker to become CFO effective July 1, 2026; David Wambeke hired as CBO."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-054744","json":"https://secwatch.observer/filing/0001213900-26-054744.json","markdown":"https://secwatch.observer/filing/0001213900-26-054744.md","text":"https://secwatch.observer/filing/0001213900-26-054744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026054744/0001213900-26-054744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026054744/ea0290094-8k_neuroone.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T12:19:13.583374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"500b2ac4edd439aab3b8a179164c1c93134f7ac6","claim":"NEUROONE MEDICAL TECHNOLOGIES Corp reported financial results for the fiscal quarter ended March 31, 2026.","evidence_excerpt":"On May 12, 2026, NeuroOne Medical Technologies Corporation (the \"Company\") issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1500198/000121390026054744/0001213900-26-054744-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended March 31, 2026"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}